Literature DB >> 28783987

Mass spectrometry-based proteomics in cancer research.

William C Cho1.   

Abstract

Entities:  

Keywords:  Cancer; MIAPE; biomarker; mass spectrometry; proteomics

Mesh：

Substances：

Year:  2017        PMID： 28783987     DOI： 10.1080/14789450.2017.1365604

Source DB:  PubMed          Journal:  Expert Rev Proteomics        ISSN： 1478-9450            Impact factor:   3.940


× No keyword cloud information.
  7 in total

1.  Multiplex targeted mass spectrometry assay for one-shot flavivirus diagnosis.

Authors:  Sheena Wee; Asfa Alli-Shaik; Relus Kek; Hannah L F Swa; Wei-Ping Tien; Vanessa W Lim; Yee-Sin Leo; Lee-Ching Ng; Hapuarachchige C Hapuarachchi; Jayantha Gunaratne
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-18       Impact factor: 11.205

Review 2.  Quantitative Proteomics and Metabolomics Reveal Biomarkers of Disease as Potential Immunotherapy Targets and Indicators of Therapeutic Efficacy.

Authors:  Melanie A MacMullan; Zachary S Dunn; Nicolas Graham; Lili Yang; Pin Wang
Journal:  Theranostics       Date:  2019-10-15       Impact factor: 11.556

Review 3.  Computational Oncology in the Multi-Omics Era: State of the Art.

Authors:  Guillermo de Anda-Jáuregui; Enrique Hernández-Lemus
Journal:  Front Oncol       Date:  2020-04-07       Impact factor: 6.244

4.  Research status and prospects of biomarkers for nasopharyngeal carcinoma in the era of high‑throughput omics (Review).

Authors:  Shan-Qiang Zhang; Su-Ming Pan; Si-Xian Liang; Yu-Shuai Han; Hai-Bin Chen; Ji-Cheng Li
Journal:  Int J Oncol       Date:  2021-03-02       Impact factor: 5.650

5.  In situ Detecting Lipids as Potential Biomarkers for the Diagnosis and Prognosis of Intrahepatic Cholangiocarcinoma.

Authors:  Jiayi Li; Qiao Chen; Lei Guo; Ji Li; Bao Jin; Xiangan Wu; Yue Shi; Haifeng Xu; Yongchang Zheng; Yingyi Wang; Shunda Du; Zhili Li; Xin Lu; Xinting Sang; Yilei Mao
Journal:  Cancer Manag Res       Date:  2022-09-26       Impact factor: 3.602

Review 6.  Strategies for Functional Interrogation of Big Cancer Data Using Drosophila Cancer Models.

Authors:  Erdem Bangi
Journal:  Int J Mol Sci       Date:  2020-05-26       Impact factor: 5.923

7.  The lncRNA ALMS1-IT1 may promote malignant progression of lung adenocarcinoma via AVL9-mediated activation of the cyclin-dependent kinase pathway.

Authors:  Tian Luan; Tian-Ye Zhang; Zhong-Hua Lv; Bi-Xi Guan; Jian-Yu Xu; Jian Li; Ming-Xu Li; Song-Liu Hu
Journal:  FEBS Open Bio       Date:  2021-04-03       Impact factor: 2.693
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.